Activated endothelial cells induce apoptosis in lymphoma cells: Role of nitric oxide

International Journal of Oncology

Volumn 10, Issue 3, 1997, Pages 465-471

  Umansky, Victor ^a   Bucur, Mariana ^a   Schirrmacher, Volker ^a   Rocha, Marian ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

apoptosis; endothelial cells; lymphoma; nitric oxide

Indexed keywords

GLYCERYL TRINITRATE; NITROUS OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0030948593     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Nicolson GL: Organ specificity of tumor metastasis: Role of preferential adhesion, invasion, and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7: 143-188, 1989.
2. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995.
3. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS and Gimbrone MA: Interleukin acts on cultured human vascular endothelial cells to increase the adhesion of polymorphonuclear leucocytes, monocytes and the related cell lines. J Clin Invest 76: 2003-2011, 1985.
4. Li L, Kilbourn RG, Adams J and Fidler IJ: Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51: 2531-2535, 1991.
5. Li L, Nicolson GL and Fidler IJ: Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res 51: 245-254, 1991.
6. Moncada S, Palmer RJ and Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991.
7. Suschek C, Rothe H, Fechsel K, Enczmann J and Kolb-Bachofen V: Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells: IL-1β mediated induction regulated by TNF-α and IFN-γ J Immunol 151: 3283-3291, 1993.
8. Rees DD, Palmer RMJ and Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86: 3375-3378, 1989.
9. Salvemini D, Korbut R, Anggard E and Vane J: Immediate release of nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 87: 2593-2597, 1990.
10. Fechsel K, Krönke KD, Meyer KL, Huber H, Wahn V and Kolb-Bachofen V: Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 155: 2858-2865, 1995.
11. Albina JE, Cui S, Mateo RB and Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150: 5080-5085, 1993.
12. Cui S, Reichner JS and Albina JE: Nitric oxide (NO) induces apoptosis in Con A-stimulated splenocytes. FASEB J 8: 4470-4475, 1994.
13. 2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J Neuropathol Exp Neurol 55: 36-43, 1996.
14. Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C and Fidler IJ: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181: 1333-1343, 1995.
15. Wyllie AH, Kerr JFR and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
16. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
17. Williams GT and Smith CA: Molecular regulation on apoptosis: genetic control on cell death. Cell 74: 777-779, 1993.
18. Raff MC: Social control on cell survival and cell death. Nature 356: 397-400, 1992.
19. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
20. Frisch SM and Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626, 1994.
21. Krüger A, Schirrmacher V and von Hoegen P: Scattered micrometastasis visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58: 275-284, 1994.
22. Krüger A, Umansky V, Rocha M, Hacker HJ, Schirrmacher V and von Hoegen P: Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 84: 3166-3174, 1994.
23. Rocha M, Krüger A, van Rooijen N, Schirrmacher V and Umansky V: Liver endothelial cells participate in T cell dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. Int J Cancer 63: 405-411, 1995.
24. Nawroth P and Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Mcd 163: 740-745, 1986.
25. 15N) nitrate in biological fluids. Anal Biochem 126: 131-138, 1982.
26. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Method 139: 271-279, 1991.
27. Schirrmacher V: Immunity and metastasis: In situ activation of protective T-cells by virus modified cancer vaccines. Cancer Surv 13: 129-154, 1992.
28. Rosenberg SA: Immunotherapy and gene therapy of cancer. Cancer Res 51: 5074-5079, 1991.
29. Whitworth PW, Pak CC, Esgro J, Kleinerman ES and Fidler IJ: Macrophages and cancer. Cancer Metastasis Rev 8: 319-351, 1990.
30. Miller FR: Immune mechanisms in the sequential steps of metastasis. Crit Rev Oncogen 4: 293-311, 1993.
31. Belloni PN and Tressler RJ: Microvascular endothelial cell heterogeneity: interactions with leucocytes and tumor cells. Cancer Metastasis Rev 8: 353-389, 1990.
32. Sato H and Suzuki M: Deformability and viability of tumor cells by transcapillary passage with reference to organ affinity in metastasis of cancer. In: Fundamental aspects of metastasis. Weiss L (ed.) North Holland, Amsterdam, pp317-331, 1976.
33. Jacobson MD, Burne JF and Raff MC: Programmed cell death and Bcl-2 protection in the absense of a nucleus. EMBO J 13: 1899-1910, 1994.
34. Stuehr DJ and Nathan CF: Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543-1555, 1989.
35. Kwon NS, Stuehr DJ and Nathan CF: Inhibition of tumor cell ribonucleotide ribonuclease by macrophage-derived nitric oxide. J Exp Med 174: 761-767, 1991.
36. Kurose I, Miura S, Fukumura D, Yonei Y, Saito H, Tada S, Suematsu M and Tsuchiya M: Nitric oxide mediates Kupffer cell-induced reduction of mitochondrial energization in hepatoma cells. A comparison with oxidative burst. Cancer Res 53: 2676-2682, 1993.
37. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Willie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852, 1993.
38. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994.
39. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL and Korsmeyer SJ: Cloning the chromosomal breakpoint of t(14;18) human Iymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41: 899-906, 1985.
40. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL and Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251, 1993.
41. Castle VP, Heidelberger JB, Ou X, Dole M and Nunes Z: Expression of the apoptosis-supressing protein bcl-2, in neuroblastoma is associated with unfavourable histology and N-myc amplification. Am J Pathol 143: 1543-1550, 1993.
42. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh J-T, Tu S-M and Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52: 6940-6944, 1992.
43. Hague A, Moorghen M, Hicks D, Chapman M and Paraskeva C: Bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene 9: 3367-3370, 1994.